Christopher M. Tegley

1.7k total citations
22 papers, 667 citations indexed

About

Christopher M. Tegley is a scholar working on Genetics, Molecular Biology and Toxicology. According to data from OpenAlex, Christopher M. Tegley has authored 22 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Toxicology. Recurrent topics in Christopher M. Tegley's work include Estrogen and related hormone effects (13 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Christopher M. Tegley is often cited by papers focused on Estrogen and related hormone effects (13 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Christopher M. Tegley collaborates with scholars based in United States. Christopher M. Tegley's co-authors include Todd K. Jones, Keith B. Marschke, Lin Zhi, Dale E. Mais, Barbara Pio, James P. Edwards, Marco M. Gottardis, William T. Schrader, Sarah J. West and Philip Tagari and has published in prestigious journals such as Journal of the American Chemical Society, Neuron and Analytical Biochemistry.

In The Last Decade

Christopher M. Tegley

22 papers receiving 636 citations

Peers

Christopher M. Tegley

GENET

EDM

Jenny Roy Canada

Richard E. Mewshaw United States

Joseph P. Burkhart United States

Charles D. Jones United States

P. CATSOULACOS Greece

Sotiris S. Nikolaropoulos Greece

Mihály Szécsi Hungary

M.J. Carr Ireland

René Maltais Canada

Manolis A. Fousteris Greece

Jenny Roy Canada

Christopher M. Tegley

250 ×0.9

333 ×1.3

338 ×1.7

GENET

55 ×0.6

181 ×2.1

EDM

Citations per year, relative to Christopher M. Tegley Christopher M. Tegley (= 1×) peers Jenny Roy

Countries citing papers authored by Christopher M. Tegley

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Tegley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Tegley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Tegley more than expected).

Fields of papers citing papers by Christopher M. Tegley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Tegley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Tegley. The network helps show where Christopher M. Tegley may publish in the future.

Co-authorship network of co-authors of Christopher M. Tegley

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Tegley. A scholar is included among the top collaborators of Christopher M. Tegley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Tegley. Christopher M. Tegley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bratkowski, Matthew, Thomas C. Burdett, Jean Danao, et al.. (2022). Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron. 110(22). 3711–3726.e16. 40 indexed citations

Kopecky, David J., Laurie P. Volak, Michael D. Bartberger, et al.. (2020). Systematic Study of the Glutathione Reactivity of N -Phenylacrylamides: 2. Effects of Acrylamide Substitution. Journal of Medicinal Chemistry. 63(20). 11602–11614. 44 indexed citations

Tegley, Christopher M., Vellarkad N. Viswanadhan, Kaustav Biswas, et al.. (2008). Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation. Bioorganic & Medicinal Chemistry Letters. 18(14). 3925–3928. 39 indexed citations

Kurzeja, Robert J., et al.. (2008). Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology. Analytical Biochemistry. 384(2). 213–223. 63 indexed citations

Higuchi, Robert I., Anthony W. Thompson, Thomas R. Caferro, et al.. (2007). Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones. Bioorganic & Medicinal Chemistry Letters. 17(19). 5442–5446. 13 indexed citations

Oeveren, Arjan van, Barbara Pio, Christopher M. Tegley, et al.. (2007). Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones. Bioorganic & Medicinal Chemistry Letters. 17(6). 1523–1526. 27 indexed citations

Poppe, Leszek, Timothy S. Harvey, Christopher Mohr, et al.. (2007). Discovery of Ligands for Nurr1 by Combined Use of NMR Screening with Different Isotopic and Spin-Labeling Strategies. SLAS DISCOVERY. 12(3). 301–311. 23 indexed citations

Kim, Tae‐Seong, Christopher M. Tegley, Xianghong Wang, et al.. (2003). (4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 87–90. 6 indexed citations

Zhi, Lin, Christopher M. Tegley, Barbara Pio, et al.. (2003). Synthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. 13(12). 2071–2074. 14 indexed citations

10.

Zhi, Lin, Christopher M. Tegley, Barbara Pio, et al.. (2003). Synthesis and Biological Activity of 5‐Methylidene 1,2‐Dihydrochromeno[3,4‐f]quinoline Derivatives as Progesterone Receptor Modulators.. ChemInform. 34(39). 2 indexed citations

11.

Lin, Zhi, James P. Edwards, Christopher M. Tegley, et al.. (2003). Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore. Bioorganic & Medicinal Chemistry Letters. 13(12). 2075–2078. 25 indexed citations

12.

Larsen, Scott D., Mark A. Connell, Paul D. May, et al.. (2001). Synthesis and Biological Activity of Analogues of the Antidiabetic/Antiobesity Agent 3-Guanidinopropionic Acid: Discovery of a Novel Aminoguanidinoacetic Acid Antidiabetic Agent. Journal of Medicinal Chemistry. 44(8). 1217–1230. 53 indexed citations

13.

Tegley, Christopher M., Barbara Pio, Sarah J. West, et al.. (2000). Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines. Bioorganic & Medicinal Chemistry Letters. 10(5). 415–418. 34 indexed citations

14.

Zhi, Lin, Christopher M. Tegley, Keith B. Marschke, & Todd K. Jones. (1999). Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone. Bioorganic & Medicinal Chemistry Letters. 9(7). 1009–1012. 48 indexed citations

15.

Zhi, Lin, Christopher M. Tegley, Keith B. Marschke, Dale E. Mais, & Todd K. Jones. (1999). 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a Novel Class of Nonsteroidal Progesterone Receptor Agonists: Effect of A-Ring Modification. Journal of Medicinal Chemistry. 42(8). 1466–1472. 28 indexed citations

16.

Hamann, Lawrence G., David T. Winn, Christopher M. Tegley, et al.. (1998). Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines. Bioorganic & Medicinal Chemistry Letters. 8(19). 2731–2736. 19 indexed citations

17.

Tegley, Christopher M., James P. Edwards, Sarah J. West, et al.. (1998). 5-Alkyl 1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal progesterone receptor modulators. Bioorganic & Medicinal Chemistry Letters. 8(23). 3365–3370. 12 indexed citations

18.

Tegley, Christopher M., et al.. (1998). 5-Benzylidene 1,2-Dihydrochromeno[3,4-f]quinolines, A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists. Journal of Medicinal Chemistry. 41(22). 4354–4359. 19 indexed citations

19.

Zhi, Lin, Christopher M. Tegley, E. Adam Kallel, et al.. (1998). 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists. Journal of Medicinal Chemistry. 41(3). 291–302. 51 indexed citations

20.

Edwards, James P., Zhi Lin, Christopher M. Tegley, et al.. (1998). Preparation, Resolution, and Biological Evaluation of 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines: Potent, Orally Active, Nonsteroidal Progesterone Receptor Agonists. Journal of Medicinal Chemistry. 41(15). 2779–2785. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact